ABOUT THE PRODUCT
A virus-like particle (VLP) based immunotherapy designed to selectively eliminate senescent cells, addressing the root cause of atherosclerosis and other age-related diseases. The vaccine induces an immune response to clear senescent cells, promoting tissue regeneration and reversing plaque burden.
Information is owner-confirmed
Last updated 1 month ago
Price range